Skip to main content

Table 1 Characteristics of recorded isolates in each participating hospital

From: Emergence of a mupirocin-resistant, methicillin-susceptible Staphylococcus aureus clone associated with skin and soft tissue infections in Greece

 

2014

2015

2016

2017

2018

TOTAL

UGHP

PAKCH

UGHL

UGHP

PAKCH

UGHL

UGHP

PAKCH

UGHL

UGHP

PAKCH

UGHL

UGHP

PAKCH

UGHL

 

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

Number (%)

SSTIs

1111

335

697

1112

384

789

1443

509

986

1527

543

905

1505

511

887

13244

SA

388 (34.9)

279 (83.3)

254 (36.4)

477 (42.9)

337 (87.8)

335 (42.5)

635 (44.0)

433 (85.1)

384 (38.9)

543 (35.6)

470 (86.6)

378 (41.8)

536 (35.6)

445 (87.1)

251 (28.3)

6145 (46.4)

MSSA

246 (63.4)

211 (75.6)

157 (61.8)

347 (72.7)

274 (81.3)

198 (59.1)

527 (83)

379 (87.5)

243 (63.3)

468 (86.2)

430 (91.5)

240 (63.5)

519 (96.8)

390 (87.6)

177 (70.5)

4806 (78.2)

MUP-R

15 (6.1)

74 (35.1)

12 (7.6)

51 (14.7)

107 (39.1)

23 (11.6)

128 (24.3)

230 (60.7)

38 (15.6)

89 (19)

316 (73.5)

35 (14.6)

92 (17.7)

245 (62.8)

29 (16.4)

1484 (30.9)

MA

5 (33.3)

10 (13.5)

5 (41.7)

18 (35.3)

10 (9.3)

8 (34.8)

38 (29.7)

25 (10.9)

15 (39.5)

26 (29.2)

36 (11.4)

11 (31.4)

23 (25.0)

22 (9.0)

8 (27.6)

260 (17.5)

  1. SA S. aureus from recorded SSTIs, MSSA Methicillin-susceptible isolates among S. aureus, MUP-R mupirocin-resistant strains among MSSA, MA molecularly analyzed strains